Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruihan Xu

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|November 5, 2020
Potential role of Methoprene-tolerant (Met) in methyl farnesoate-mediated vitellogenesis in the Chinese mitten crab (Eriocheir sinensis)Xilei Li, Tiantian Chen, Yang Han, et al.
Journal of Hematology & Oncology|March 19, 2022
In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumorsZhichen Sun, Rutian Li, Yun Shen, et al.
Pharmacological Research|January 4, 2020
Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD- L1-dependent T cell immunizationRuihan Xu, Jian Wu, Xingxing Zhang, et al.
Toxics|May 27, 2026
Developmental Toxicity and Thyroid-Disrupting Effects of Combined Exposure to Pb(II) and <sup>210</sup>Pb(II) in Zebrafish EmbryosChao Xu, Yuanzhen Li, Lisha Chen, et al.
Nanoscale|September 12, 2023
Anisotropic charge transfer and gate tuning for p-SnS/n-MoS<sub>2</sub> vertical van der Waals diodesHui Yuan, Ruihan Xu, Jiale Ren, et al.
ACS Applied Materials & Interfaces|May 28, 2026
High-Entropy Oxide Interlayers Enable Coordinated Regulation of Zn<sup>2+</sup> Interfacial Kinetics for Stable Zinc Metal AnodesRuihan Xu, Shiyu Xia, Jing Zhao, et al.
Medcomm|July 8, 2024
Liposome-based in situ antigen-modification strategy for "universal" T-cell-receptor engineered T cell in cancer immunotherapyQin Wang, Rui Peng, Haoyue Qi, et al.
Bioengineering & Translational Medicine|November 29, 2023
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumorRuihan Xu, Qin Wang, Junmeng Zhu, et al.
Frontiers in Immunology|June 24, 2025
LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysisLi Zhu, Juanjuan Ruan, Qing Zhang, et al.
Cancer Science|September 19, 2021
Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccinationYanhong Chu, Rutian Li, Lingyu Qian, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|November 5, 2020
Potential role of Methoprene-tolerant (Met) in methyl farnesoate-mediated vitellogenesis in the Chinese mitten crab (Eriocheir sinensis)Xilei Li, Tiantian Chen, Yang Han, et al.
Journal of Hematology & Oncology|March 19, 2022
In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumorsZhichen Sun, Rutian Li, Yun Shen, et al.
Pharmacological Research|January 4, 2020
Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD- L1-dependent T cell immunizationRuihan Xu, Jian Wu, Xingxing Zhang, et al.
Toxics|May 27, 2026
Developmental Toxicity and Thyroid-Disrupting Effects of Combined Exposure to Pb(II) and <sup>210</sup>Pb(II) in Zebrafish EmbryosChao Xu, Yuanzhen Li, Lisha Chen, et al.
Nanoscale|September 12, 2023
Anisotropic charge transfer and gate tuning for p-SnS/n-MoS<sub>2</sub> vertical van der Waals diodesHui Yuan, Ruihan Xu, Jiale Ren, et al.
ACS Applied Materials & Interfaces|May 28, 2026
High-Entropy Oxide Interlayers Enable Coordinated Regulation of Zn<sup>2+</sup> Interfacial Kinetics for Stable Zinc Metal AnodesRuihan Xu, Shiyu Xia, Jing Zhao, et al.
Medcomm|July 8, 2024
Liposome-based in situ antigen-modification strategy for "universal" T-cell-receptor engineered T cell in cancer immunotherapyQin Wang, Rui Peng, Haoyue Qi, et al.
Bioengineering & Translational Medicine|November 29, 2023
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumorRuihan Xu, Qin Wang, Junmeng Zhu, et al.
Frontiers in Immunology|June 24, 2025
LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysisLi Zhu, Juanjuan Ruan, Qing Zhang, et al.
Cancer Science|September 19, 2021
Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccinationYanhong Chu, Rutian Li, Lingyu Qian, et al.
Pageof 5